BRPI0507580A - métodos para o isolamento e purificação do composto, e, para a fabricação de escitalopram - Google Patents

métodos para o isolamento e purificação do composto, e, para a fabricação de escitalopram

Info

Publication number
BRPI0507580A
BRPI0507580A BRPI0507580-7A BRPI0507580A BRPI0507580A BR PI0507580 A BRPI0507580 A BR PI0507580A BR PI0507580 A BRPI0507580 A BR PI0507580A BR PI0507580 A BRPI0507580 A BR PI0507580A
Authority
BR
Brazil
Prior art keywords
compound
escitalopram
manufacture
methods
derivative
Prior art date
Application number
BRPI0507580-7A
Other languages
English (en)
Inventor
Lars Ole Lyngso
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36603240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0507580(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BRPI0507580A publication Critical patent/BRPI0507580A/pt
Publication of BRPI0507580B1 publication Critical patent/BRPI0507580B1/pt
Publication of BRPI0507580B8 publication Critical patent/BRPI0507580B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

MéTODOS PARA O ISOLAMENTO E PURIFACAçãO DO COMPOSTO, E, PARA A FABRICAçãO DE ESCITALOPRAM. A invenção refere-se a um método de separação e isolamento de um derivado acilado de 4-¢(S)-4-dimeti-ilamino-1-(4-fluorofeinil)-1-hidroxibutil!-3-hidroximetilbe nzonitrila por reação de uma mistura de 4-¢(S)-4-dimeti-ilamino-1-(4-fluorofenil)-1-hidróxi-butil!-3-hidroximetil-be nzonitrila e um derivado acilado da mesma com um composto que forma um derivado de 4-¢(S)-4-dimetilamino-1-(4-fluorofenil)-1-hidróxi-butil!-3-hidroximetibenz onitrila contendo um grupo de ácido carboxílico. O derivado acilado contendo um grupo de ácido carboxílico precipita uma vez que ele é formado e pode facilmente ser separado da mistura de reação.
BRPI0507580A 2004-02-12 2005-02-02 métodos para o isolamento e purificação do composto, e, para a fabricação de escitalopram BRPI0507580B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54497004P 2004-02-12 2004-02-12
US60/544,970 2004-02-12
DKPA200400217 2004-02-12
DKPA200400217 2004-02-12
PCT/DK2005/000075 WO2005077891A1 (en) 2004-02-12 2005-02-02 Method for the separation of intermediates which may be used for the preparation of escitalopram

Publications (3)

Publication Number Publication Date
BRPI0507580A true BRPI0507580A (pt) 2007-07-31
BRPI0507580B1 BRPI0507580B1 (pt) 2018-01-09
BRPI0507580B8 BRPI0507580B8 (pt) 2021-05-25

Family

ID=36603240

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507580A BRPI0507580B8 (pt) 2004-02-12 2005-02-02 métodos para o isolamento e purificação do composto, e, para a fabricação de escitalopram

Country Status (26)

Country Link
US (1) US7582780B2 (pt)
EP (1) EP1716108B1 (pt)
JP (1) JP4975450B2 (pt)
KR (1) KR101156495B1 (pt)
CN (1) CN1918112B (pt)
AR (1) AR047522A1 (pt)
AT (1) ATE411278T1 (pt)
AU (1) AU2005212455A1 (pt)
BR (1) BRPI0507580B8 (pt)
CA (1) CA2555980C (pt)
DK (1) DK1716108T3 (pt)
EA (1) EA012503B1 (pt)
ES (1) ES2315832T3 (pt)
IL (1) IL177365A0 (pt)
MY (1) MY144749A (pt)
NZ (1) NZ548441A (pt)
PE (1) PE20051139A1 (pt)
PL (1) PL1716108T3 (pt)
PT (1) PT1716108E (pt)
RS (1) RS50689B (pt)
SI (1) SI1716108T1 (pt)
TW (1) TWI339651B (pt)
UA (1) UA86403C2 (pt)
UY (1) UY28743A1 (pt)
WO (1) WO2005077891A1 (pt)
ZA (1) ZA200606639B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN108640856B (zh) * 2018-06-11 2021-06-25 淮阴工学院 一种依地普仑中间体的不对称合成方法及其中间体

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
WO2000023431A1 (en) 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
GB2360281B (en) * 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
SK14602002A3 (sk) 2000-03-13 2003-02-04 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
BR0109364A (pt) 2000-03-13 2002-12-24 Lundbeck & Co As H Métodos para fabricação de citalopram através de alquilação escalonada de 5-substituìda 1- (4-fluorofenil) - 1,3- diidroisobenzofuranos e citalopram
IL151488A0 (en) 2000-03-14 2003-04-10 Lundbeck & Co As H Method for the preparation of citalopram
TR200202168T2 (tr) 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
ES2194597B2 (es) * 2002-01-25 2004-08-01 Esteve Quimica, S.A. Procedimiento para la obtencion de citalopram.
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
CA2381341A1 (en) * 2002-04-09 2003-10-09 Torcan Chemical Ltd. Process and intermediates for preparing escitalopram
AR040970A1 (es) * 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
JP4505335B2 (ja) * 2002-12-23 2010-07-21 ハー・ルンドベック・アクチエゼルスカベット ラセミ体シタロプラムジオール(racemiccitalopramdiol)および/またはS−もしくはR−シタロプラムジオールの製造方法、およびラセミ体シタロプラム、R−シタロプラムおよび/またはS−シタロプラムを製造するために、上記ジオールを使用する方法。

Also Published As

Publication number Publication date
KR101156495B1 (ko) 2012-07-06
BRPI0507580B1 (pt) 2018-01-09
CN1918112B (zh) 2011-11-23
UY28743A1 (es) 2005-09-30
WO2005077891A1 (en) 2005-08-25
NZ548441A (en) 2009-12-24
PT1716108E (pt) 2008-12-31
MY144749A (en) 2011-10-31
JP4975450B2 (ja) 2012-07-11
IL177365A0 (en) 2006-12-10
CA2555980A1 (en) 2005-08-25
AR047522A1 (es) 2006-01-25
KR20060116222A (ko) 2006-11-14
CN1918112A (zh) 2007-02-21
BRPI0507580B8 (pt) 2021-05-25
JP2007524678A (ja) 2007-08-30
PL1716108T3 (pl) 2009-04-30
UA86403C2 (uk) 2009-04-27
RS50689B (sr) 2010-06-30
EP1716108A1 (en) 2006-11-02
AU2005212455A1 (en) 2005-08-25
TWI339651B (en) 2011-04-01
HK1100922A1 (en) 2007-10-05
ES2315832T3 (es) 2009-04-01
DK1716108T3 (da) 2009-01-19
CA2555980C (en) 2010-08-03
ZA200606639B (en) 2007-12-27
US7582780B2 (en) 2009-09-01
US20070190624A1 (en) 2007-08-16
EA200601469A1 (ru) 2006-12-29
SI1716108T1 (sl) 2009-02-28
EA012503B1 (ru) 2009-10-30
ATE411278T1 (de) 2008-10-15
PE20051139A1 (es) 2006-01-28
TW200530210A (en) 2005-09-16
EP1716108B1 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
BRPI0915692B8 (pt) compostos derivados de 1,2,5-oxadiazóis, sua forma sólida, sua composição, bem como seus usos
NO20045589L (no) Nye forbindelser
CY1109760T1 (el) Παραγωγα ινδολης-3-θειου
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
BR112012025729A2 (pt) purificação por adsorção de caramelo
ECSP088876A (es) Formas de polimorfos de la (2s)-(4e)-n-metil-5-(3-isopropoxipiridin)il]-4-penten-2-amina para el tratamiento de desórdenes del sistema nervioso central
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
BR112017021789A2 (pt) processo para isolamento e purificação de ambrox
EA200700909A1 (ru) Азаиндолкарбоксамиды
EA200602115A1 (ru) Опиоидные соединения, замещенные карбоксамидогруппой
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE483679T1 (de) Substituierte cyclohexylessigsäure-derivate
BRPI0514419A (pt) amidas do ácido tienopirrol carboxìlico substituìdas, amidas do ácido pirrolotiazol carboxìlico, e análogos relacionados como inibidores de caseìna cinase iépsilon, bem como composição farmacêutica e processo para a preparação dos mesmos
ATE510812T1 (de) Verfahren zur reinigung von cyclischen ketonen
BRPI0507580B8 (pt) métodos para o isolamento e purificação do composto, e, para a fabricação de escitalopram
WO2011067356A3 (en) Polymorphs of a mek inhibitor
MX2012005597A (es) Formas cristalinas de pirazolopirimidinas sustituidas.
ZA200903810B (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
NO20090646L (no) Xinafoatsalt av en substituert 5-oksazol-2-yl-kinolinforbindelse
MX2007002808A (es) Proceso para el aislamiento de tacrolimus cristalino.
EA200801878A1 (ru) Энзиматический метод разделения рацемической 3-арил-4-аминомасляной кислоты
SA112330847B1 (ar) عملية لتحضير حمض ميثاكريليك وإسترات حمض ميثاكريليك‏
DE602007013426D1 (de) Verfahren zur selektiven isolierung, aufreinigung und auftrennung von monohydroxylierten 3,17-diketosteroidverbindungen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/02/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF